Search Results
Laura Ximena Kattah Martinez
Laura Ximena Kattah Martinez
Pontificia Universidad Javeriana, Bogotá, Colombia
Search for other papers by Laura Ximena Kattah Martinez in
Google Scholar
PubMed
Search for other papers by Laura Ximena Kattah Martinez in
Google Scholar
PubMed
Lisseth Fernanda Marín Carrillo
Lisseth Fernanda Marín Carrillo
Pontificia Universidad Javeriana, Bogotá, Colombia
Search for other papers by Lisseth Fernanda Marín Carrillo in
Google Scholar
PubMed
Search for other papers by Lisseth Fernanda Marín Carrillo in
Google Scholar
PubMed
Leonardo Rojas Melo
Leonardo Rojas Melo
Pontificia Universidad Javeriana, Bogotá, Colombia
Search for other papers by Leonardo Rojas Melo in
Google Scholar
PubMed
Search for other papers by Leonardo Rojas Melo in
Google Scholar
PubMed
and Drug Administration in 2005. Recently, it demonstrated improvement in progression-free survival (PFS) in radioactive iodine (RAI)-refractory locally advanced or metastatic differentiated thyroid cancer (DTC), a setting for which it has been
Francisco Sousa Santos
Francisco Sousa Santos
Endocrinology Department, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal
Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Search for other papers by Francisco Sousa Santos in
Google Scholar
PubMed
Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Search for other papers by Francisco Sousa Santos in
Google Scholar
PubMed
Rita Joana Santos
Rita Joana Santos
Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Search for other papers by Rita Joana Santos in
Google Scholar
PubMed
Search for other papers by Rita Joana Santos in
Google Scholar
PubMed
Valeriano Leite
Valeriano Leite
Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Faculty of Medical Sciences of Lisbon, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Faculty of Medical Sciences of Lisbon, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
. 10.1530/EJE-16-0202 27666535 0804-4643 7 Brose MS , Nutting CM , Jarzab B , Elisei R , Siena S , Bastholt L , et al. ; DECISION investigators . Sorafenib in radioactive iodine-refractory, locally advanced or metastatic
Pepijn van Houten
Pepijn van Houten
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Pepijn van Houten in
Google Scholar
PubMed
Search for other papers by Pepijn van Houten in
Google Scholar
PubMed
James Nagarajah
James Nagarajah
Roentgeninstitut Duesseldorf, Duesseldorf, Germany
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by James Nagarajah in
Google Scholar
PubMed
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by James Nagarajah in
Google Scholar
PubMed
Janneke E W Walraven
Janneke E W Walraven
Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Janneke E W Walraven in
Google Scholar
PubMed
Search for other papers by Janneke E W Walraven in
Google Scholar
PubMed
Martin Jaeger
Martin Jaeger
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Adriana C H van Engen-van Grunsven
Adriana C H van Engen-van Grunsven
Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Adriana C H van Engen-van Grunsven in
Google Scholar
PubMed
Search for other papers by Adriana C H van Engen-van Grunsven in
Google Scholar
PubMed
Johannes W Smit
Johannes W Smit
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
Romana T Netea-Maier
Romana T Netea-Maier
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
therapy in specific groups of RAI-refractory NMTC patients, for most patients, redifferentiation options are lacking. Table 2 Overview of human studies showing effective reinduction of radioactive iodine uptake in RAI-refractory NMTC patients
Alice Nervo
Alice Nervo
Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy
Search for other papers by Alice Nervo in
Google Scholar
PubMed
Search for other papers by Alice Nervo in
Google Scholar
PubMed
Alberto Ragni
Alberto Ragni
Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy
Search for other papers by Alberto Ragni in
Google Scholar
PubMed
Search for other papers by Alberto Ragni in
Google Scholar
PubMed
Alessandro Piovesan
Alessandro Piovesan
Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy
Search for other papers by Alessandro Piovesan in
Google Scholar
PubMed
Search for other papers by Alessandro Piovesan in
Google Scholar
PubMed
Valentina Marica
Valentina Marica
Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy
Search for other papers by Valentina Marica in
Google Scholar
PubMed
Search for other papers by Valentina Marica in
Google Scholar
PubMed
Enrica Migliore
Enrica Migliore
Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy
Search for other papers by Enrica Migliore in
Google Scholar
PubMed
Search for other papers by Enrica Migliore in
Google Scholar
PubMed
Marco Gallo
Marco Gallo
Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy
Search for other papers by Marco Gallo in
Google Scholar
PubMed
Search for other papers by Marco Gallo in
Google Scholar
PubMed
Emanuela Arvat
Emanuela Arvat
Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Città della Salute e della Scienza Hospital, Turin, Italy
Search for other papers by Emanuela Arvat in
Google Scholar
PubMed
Search for other papers by Emanuela Arvat in
Google Scholar
PubMed
Introduction Treatment with lenvatinib (LEN), a multitarget tyrosine kinase inhibitor (TKI), has shown great efficacy in patients with advanced radioactive iodine-refractory (RAI-R) thyroid cancer (TC), both in clinical trials and in a real
Clotilde Saïe
Clotilde Saïe
Thyroid and Endocrine Tumors Unit, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France
Search for other papers by Clotilde Saïe in
Google Scholar
PubMed
Search for other papers by Clotilde Saïe in
Google Scholar
PubMed
Cécile Ghander
Cécile Ghander
Thyroid and Endocrine Tumors Unit, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France
Search for other papers by Cécile Ghander in
Google Scholar
PubMed
Search for other papers by Cécile Ghander in
Google Scholar
PubMed
Samir Saheb
Samir Saheb
Apheresis Unit, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France
Search for other papers by Samir Saheb in
Google Scholar
PubMed
Search for other papers by Samir Saheb in
Google Scholar
PubMed
Christel Jublanc
Christel Jublanc
Department of Endocrinology, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France
Search for other papers by Christel Jublanc in
Google Scholar
PubMed
Search for other papers by Christel Jublanc in
Google Scholar
PubMed
Denis Lemesle
Denis Lemesle
Department of Anaesthesia, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France
Search for other papers by Denis Lemesle in
Google Scholar
PubMed
Search for other papers by Denis Lemesle in
Google Scholar
PubMed
Charlotte Lussey-Lepoutre
Charlotte Lussey-Lepoutre
Nuclear Medicine Department, Pitié-Salpêtrière Hospital APHP, Sorbonne Université, Inserm U970, Paris, France
Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed
Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed
Laurence Leenhardt
Laurence Leenhardt
Thyroid and Endocrine Tumors Unit, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Fabrice Menegaux
Fabrice Menegaux
Department of Surgery, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France
Search for other papers by Fabrice Menegaux in
Google Scholar
PubMed
Search for other papers by Fabrice Menegaux in
Google Scholar
PubMed
Christophe Tresallet
Christophe Tresallet
Department of Surgery, Avicennes Hospital, Paris, France
Search for other papers by Christophe Tresallet in
Google Scholar
PubMed
Search for other papers by Christophe Tresallet in
Google Scholar
PubMed
Camille Buffet
Camille Buffet
Thyroid and Endocrine Tumors Unit, Pitié-Salpêtrière Hospital APHP, Sorbonne University, Paris, France
Search for other papers by Camille Buffet in
Google Scholar
PubMed
Search for other papers by Camille Buffet in
Google Scholar
PubMed
observed in 1 patient. No histopathological malignancy was detected in the 16 cases that underwent surgery. One patient was treated with radioactive iodine (355 MegaBequerel), which led to hypothyroidism without any other side effects. Severe
Andrew G Gianoukakis
Andrew G Gianoukakis
The Lundquist Institute at Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA, Torrance, California, USA
Search for other papers by Andrew G Gianoukakis in
Google Scholar
PubMed
Search for other papers by Andrew G Gianoukakis in
Google Scholar
PubMed
Jennifer H Choe
Jennifer H Choe
Department of Medicine, Duke University Medical Center/Duke Cancer Institute, Durham, North Carolina, USA
Search for other papers by Jennifer H Choe in
Google Scholar
PubMed
Search for other papers by Jennifer H Choe in
Google Scholar
PubMed
Daniel W Bowles
Daniel W Bowles
Division of Medical Oncology, University of Colorado, Aurora, Colorado, USA
Search for other papers by Daniel W Bowles in
Google Scholar
PubMed
Search for other papers by Daniel W Bowles in
Google Scholar
PubMed
Marcia S Brose
Marcia S Brose
Department of Otorhinolaryngology: Head and Neck Surgery, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for other papers by Marcia S Brose in
Google Scholar
PubMed
Search for other papers by Marcia S Brose in
Google Scholar
PubMed
Lori J Wirth
Lori J Wirth
Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA
Search for other papers by Lori J Wirth in
Google Scholar
PubMed
Search for other papers by Lori J Wirth in
Google Scholar
PubMed
Taofeek Owonikoko
Taofeek Owonikoko
Winship Cancer Institute of Emory University, Atlanta, Georgia, USA
Search for other papers by Taofeek Owonikoko in
Google Scholar
PubMed
Search for other papers by Taofeek Owonikoko in
Google Scholar
PubMed
Svetlana Babajanyan
Svetlana Babajanyan
Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA
Search for other papers by Svetlana Babajanyan in
Google Scholar
PubMed
Search for other papers by Svetlana Babajanyan in
Google Scholar
PubMed
Francis P Worden
Francis P Worden
Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, USA
Search for other papers by Francis P Worden in
Google Scholar
PubMed
Search for other papers by Francis P Worden in
Google Scholar
PubMed
. Available at: https://seer.cancer.gov/csr/1975_2017/ 2 Worden F . Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer . Therapeutic Advances in Medical Oncology 2014 6 267 – 279 . ( https://doi.org/10
Abdul Rehman Syed
Abdul Rehman Syed
University of Calgary, Calgary, Alberta, Canada
Search for other papers by Abdul Rehman Syed in
Google Scholar
PubMed
Search for other papers by Abdul Rehman Syed in
Google Scholar
PubMed
Aakash Gorana
Aakash Gorana
Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Alberta, Canada
Search for other papers by Aakash Gorana in
Google Scholar
PubMed
Search for other papers by Aakash Gorana in
Google Scholar
PubMed
Erik Nohr
Erik Nohr
Alberta Precision Laboratories, Molecular Pathology Program, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Erik Nohr in
Google Scholar
PubMed
Search for other papers by Erik Nohr in
Google Scholar
PubMed
Xiaoli-Kat Yuan
Xiaoli-Kat Yuan
Precision Oncology Hub Laboratory, Tom Baker Cancer Centre, Calgary, Alberta, Canada
Search for other papers by Xiaoli-Kat Yuan in
Google Scholar
PubMed
Search for other papers by Xiaoli-Kat Yuan in
Google Scholar
PubMed
Parthiv Amin MASc
Parthiv Amin MASc
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary Alberta, Canada
Search for other papers by Parthiv Amin MASc in
Google Scholar
PubMed
Search for other papers by Parthiv Amin MASc in
Google Scholar
PubMed
Sana Ghaznavi
Sana Ghaznavi
Arnie Charbonneau Cancer Institute, Department of Medicine, Section of Endocrinology, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Sana Ghaznavi in
Google Scholar
PubMed
Search for other papers by Sana Ghaznavi in
Google Scholar
PubMed
Debbie Lamb
Debbie Lamb
Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Alberta, Canada
Search for other papers by Debbie Lamb in
Google Scholar
PubMed
Search for other papers by Debbie Lamb in
Google Scholar
PubMed
John McIntyre
John McIntyre
Precision Oncology Hub Laboratory, Tom Baker Cancer Centre, Calgary, Alberta, Canada
Search for other papers by John McIntyre in
Google Scholar
PubMed
Search for other papers by John McIntyre in
Google Scholar
PubMed
Markus Eszlinger
Markus Eszlinger
Department of Oncology, Cumming School of Medicine, and Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Ralf Paschke
Ralf Paschke
Departments of Medicine, Section of Endocrinology, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Pasmant E Zerbit J , et al. Redifferentiating effect of larotrectinib in NTRK-rearranged advanced radioactive-iodine refractory thyroid cancer . Thyroid 2022 32 594 – 598 . ( https://doi.org/10.1089/thy.2021.0524 ) 12 Goring S & Mahood Q
Kirsten E. Stewart
Kirsten E. Stewart
Department of Head and Neck Surgery, St John’s Hospital at Howden, Livingston, United Kingdom
Search for other papers by Kirsten E. Stewart in
Google Scholar
PubMed
Search for other papers by Kirsten E. Stewart in
Google Scholar
PubMed
Mark W.J. Strachan
Mark W.J. Strachan
Metabolic Unit, Western General Hospital, Edinburgh, United Kingdom
Search for other papers by Mark W.J. Strachan in
Google Scholar
PubMed
Search for other papers by Mark W.J. Strachan in
Google Scholar
PubMed
Devraj Srinivasan
Devraj Srinivasan
Department of Oncology, Western General Hospital, Edinburgh, United Kingdom
Search for other papers by Devraj Srinivasan in
Google Scholar
PubMed
Search for other papers by Devraj Srinivasan in
Google Scholar
PubMed
Morna MacNeill
Morna MacNeill
Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
Search for other papers by Morna MacNeill in
Google Scholar
PubMed
Search for other papers by Morna MacNeill in
Google Scholar
PubMed
Lucy Wall
Lucy Wall
Department of Oncology, Western General Hospital, Edinburgh, United Kingdom
Search for other papers by Lucy Wall in
Google Scholar
PubMed
Search for other papers by Lucy Wall in
Google Scholar
PubMed
Iain J. Nixon
Iain J. Nixon
Department of Head and Neck Surgery, St John’s Hospital at Howden, Livingston, United Kingdom
Search for other papers by Iain J. Nixon in
Google Scholar
PubMed
Search for other papers by Iain J. Nixon in
Google Scholar
PubMed
deemed unsuitable for surgery, limited alternative options were available. Sorafenib and lenvatinib both showed a prolonged progression-free survival advantage in patients with radioactive iodine-refractory differentiated thyroid cancer (DTC
Xian Qiu
Xian Qiu
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Search for other papers by Xian Qiu in
Google Scholar
PubMed
Search for other papers by Xian Qiu in
Google Scholar
PubMed
Lin Cheng
Lin Cheng
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Ri Sa
Ri Sa
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, China
Search for other papers by Ri Sa in
Google Scholar
PubMed
Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, China
Search for other papers by Ri Sa in
Google Scholar
PubMed
Hao Fu
Hao Fu
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
Search for other papers by Hao Fu in
Google Scholar
PubMed
Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
Search for other papers by Hao Fu in
Google Scholar
PubMed
Yuchen Jin
Yuchen Jin
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Libo Chen
Libo Chen
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Search for other papers by Libo Chen in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
.1634/theoncologist.2015-0107 ) 4 Brose MS Nutting CM Jarzab B Elisei R Siena S Bastholt L de la Fouchardiere C Pacini F Paschke R Shong YK Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer
Carla Colombo
Carla Colombo
Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Daniele Ceruti
Daniele Ceruti
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Daniele Ceruti in
Google Scholar
PubMed
Search for other papers by Daniele Ceruti in
Google Scholar
PubMed
Simone De Leo
Simone De Leo
Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Grzegorz Bilo
Grzegorz Bilo
Department of Cardiology, San Luca Hospital, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Grzegorz Bilo in
Google Scholar
PubMed
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Grzegorz Bilo in
Google Scholar
PubMed
Matteo Trevisan
Matteo Trevisan
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Matteo Trevisan in
Google Scholar
PubMed
Search for other papers by Matteo Trevisan in
Google Scholar
PubMed
Noemi Giancola
Noemi Giancola
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Noemi Giancola in
Google Scholar
PubMed
Search for other papers by Noemi Giancola in
Google Scholar
PubMed
Claudia Moneta
Claudia Moneta
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Claudia Moneta in
Google Scholar
PubMed
Search for other papers by Claudia Moneta in
Google Scholar
PubMed
Gianfranco Parati
Gianfranco Parati
Department of Cardiology, San Luca Hospital, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Gianfranco Parati in
Google Scholar
PubMed
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Gianfranco Parati in
Google Scholar
PubMed
Luca Persani
Luca Persani
Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Laura Fugazzola
Laura Fugazzola
Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Milan, Italy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
-up of advanced radioiodine-refractory thyroid cancer . European Thyroid Journal 2019 8 227 – 245 . ( https://doi.org/10.1159/000502229 ) 2 Dadu R & Cabanillas ME . Optimizing therapy for radioactive iodine-refractory differentiated thyroid
